NCT00074529

Data

{
  "briefSummary": "An investigational drug (MK0677) will be studied to determine whether it helps the memory and cognition of patients with Alzheimer's Disease.",
  "completionDate": "2006-01",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "enrollmentCount": 512,
  "enrollmentType": "ACTUAL",
  "nctId": "NCT00074529",
  "phase": "PHASE2",
  "sponsorId": "merck-sharp-dohme-llc",
  "startDate": "2003-10",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in Slowing the Progression of Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00074529"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version